Skip to main content

The inconvenience of convenience cohorts: rhabdomyosarcoma and the PAX-FOXO1 biomarker.

Publication ,  Journal Article
Rosenberg, AR; Skapek, SX; Hawkins, DS
Published in: Cancer Epidemiol Biomarkers Prev
July 2012

"Convenience cohorts" comprise individuals thought to represent the general population, but chosen because they are readily available for evaluation, rather than at random. As such, these methods are subject to bias and may be misleading. Convenience cohorts have been used to investigate the prognostic significance of chromosomal translocations between the PAX3 or PAX7 and the FOXO1 genes in rhabdomyosarcoma, the most common pediatric sarcoma. However, retrospective studies assessing the role of PAX-FOXO1 translocations have yielded inconsistent results. This review highlights the findings from several clinical correlation studies of the PAX-FOXO1 biomarker and illustrates the challenges of using such methods to draw clinical conclusions.

Duke Scholars

Published In

Cancer Epidemiol Biomarkers Prev

DOI

EISSN

1538-7755

Publication Date

July 2012

Volume

21

Issue

7

Start / End Page

1012 / 1018

Location

United States

Related Subject Headings

  • Rhabdomyosarcoma
  • Patient Selection
  • PAX7 Transcription Factor
  • Humans
  • Forkhead Transcription Factors
  • Forkhead Box Protein O1
  • Epidemiology
  • Clinical Trials as Topic
  • Child
  • Biomarkers, Tumor
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rosenberg, A. R., Skapek, S. X., & Hawkins, D. S. (2012). The inconvenience of convenience cohorts: rhabdomyosarcoma and the PAX-FOXO1 biomarker. Cancer Epidemiol Biomarkers Prev, 21(7), 1012–1018. https://doi.org/10.1158/1055-9965.EPI-12-0207
Rosenberg, Abby R., Stephen X. Skapek, and Douglas S. Hawkins. “The inconvenience of convenience cohorts: rhabdomyosarcoma and the PAX-FOXO1 biomarker.Cancer Epidemiol Biomarkers Prev 21, no. 7 (July 2012): 1012–18. https://doi.org/10.1158/1055-9965.EPI-12-0207.
Rosenberg AR, Skapek SX, Hawkins DS. The inconvenience of convenience cohorts: rhabdomyosarcoma and the PAX-FOXO1 biomarker. Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1012–8.
Rosenberg, Abby R., et al. “The inconvenience of convenience cohorts: rhabdomyosarcoma and the PAX-FOXO1 biomarker.Cancer Epidemiol Biomarkers Prev, vol. 21, no. 7, July 2012, pp. 1012–18. Pubmed, doi:10.1158/1055-9965.EPI-12-0207.
Rosenberg AR, Skapek SX, Hawkins DS. The inconvenience of convenience cohorts: rhabdomyosarcoma and the PAX-FOXO1 biomarker. Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1012–1018.

Published In

Cancer Epidemiol Biomarkers Prev

DOI

EISSN

1538-7755

Publication Date

July 2012

Volume

21

Issue

7

Start / End Page

1012 / 1018

Location

United States

Related Subject Headings

  • Rhabdomyosarcoma
  • Patient Selection
  • PAX7 Transcription Factor
  • Humans
  • Forkhead Transcription Factors
  • Forkhead Box Protein O1
  • Epidemiology
  • Clinical Trials as Topic
  • Child
  • Biomarkers, Tumor